Literature DB >> 1169314

5-[3-(2-Chloroethyl)-1-triazenyl] imidazole-4-carboxamide and a possible mechanism of action of 5-[3, 3-bis(2-chloroethyl)-1-triazenyl] imidazole-4-carboxamide.

Y F Shealy, C A O'Dell, C A Krauth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1169314     DOI: 10.1002/jps.2600640147

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  2 in total

1.  Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.

Authors:  C Goddard; J A Slack; M F Stevens
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

2.  The effects of pretreatment of human tumour cells with MNNG on the DNA crosslinking and cytotoxicity of mitozolomide.

Authors:  N W Gibson; L C Erickson
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.